...
机译:改善肌营养侧面硬化的临床试验结果。
Brain and Mind Centre University of Sydney;
Sydney Medical School Westmead University of Sydney;
Nuffield Department of Clinical Neurosciences University of Oxford;
Sheffield Institute for Translational Neuroscience University of Sheffield;
Academic Neurology Unit Trinity Biomedical Sciences Institute Trinity College Dublin;
Department of Neurology Barrow Neurological Institute University of Arizona College of Medicine;
King's College London Maurice Wohl Clinical Neuroscience Institute Department of Basic and;
Brain and Mind Centre University of Sydney;
Massachusetts General Hospital;
Neurosciences Department Barwon Health District;
Department of Neurology UMC Utrecht Brain Center University Medical Center Utrecht;
Nuffield Department of Clinical Neurosciences University of Oxford;
Wicks Digital Health;
The Motor Neurone Disease Association of New Zealand;
Nuffield Department of Clinical Neurosciences University of Oxford;
机译:在肌萎缩性侧索硬化症的临床试验中,安慰剂并非总是必要的。
机译:设计肌萎缩性侧索硬化症的临床试验。
机译:肌萎缩性侧索硬化症的临床试验进展。
机译:肌营养侧颅骨菌病症患者心血管控制指标及其与临床标志的关系
机译:在肌萎缩性侧索硬化的小鼠模型中S6K1抑制介导的Motonuron特性变化。
机译:脊髓内注射神经干细胞在肌萎缩性侧索硬化症中的一期临床试验结果:长期结果
机译:书评:临床神经学研究进展。 1肌萎缩性侧索硬化症。
机译:用于治疗肌萎缩侧索硬化症的易位蛋白配体的临床前试验。